MSN Pharma concludes USFDA audit with zero observations

Hyderabad: MSN Pharmaceuticals Inc. (MSNPI), a wholly-owned subsidiary of MSN Group of Companies, based out of Piscataway, New Jersey, USA has successfully completed its maiden USFDA audit with zero observations.

The state-of-the-art finished dosages facility was established to bolster MSN Group's product portfolio as well as Contract Development & Manufacturing services, in the US and several other key regulatory markets.

"This is a major accomplishment for us. It augments the core strategy of establishing ourselves as a preferred Contract Development & Manufacturing Service provider globally, offering endto-end drug manufacturing services. Also, besides helping us to deepen our presence in the US market, it will enable us to make high-quality generics affordable and accessible to the patients swiftly and efficiently," MSN Group commented.

Read also: MSN Labs gets USFDA nod for generic version of Cangrelor in India